and Reirradiation
Fig. 1 Superficial hyperthermia of recurrent breast cancer 1.1.2 Interstitial and Endocavitary/Intraluminal Hyperthermia Interstitial and endocavitary/intraluminal hyperthermia (IHT) methods may be used to treat tumors within or near body cavities,…
for Locally Recurrent Breast Cancer
First author Year N Follow-up (years) Local control (%) Alpert 2005 30 13.8 93 Abner 1993 16 3.25 69 Kurtz 1991 50 4.25 62 Komoike 2003 30 3.6 70 Salvadori…
Malignancies
Series Total patients No. with prior RT Dose and fractionation Local control (LC) Toxicity Guckenberger et al. (2010) 19 7 Median dose: 15 Gy in 3 fractions prescribed to 65…
to: Re-Irradiation: New Frontiers
© Springer International Publishing 2017Carsten Nieder and Johannes Langendijk (eds.)Re-Irradiation: New FrontiersMedical Radiology10.1007/978-3-319-41825-4_78 Erratum Erratum to: Re-Irradiation: New Frontiers Carsten Nieder1 and Johannes Langendijk2 (1) Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway (2)…
for Soft Tissue Sarcomas
Study N Study dates Retreatment radiotherapy Median follow-up (mo.) 5-year local control rate (%) 5-year overall survival rate (%) Serious complications rate (%) Amputation rate (%) Nori et al. (1991)…
Tissue Tolerance to Reirradiation
Fig. 1 In 1995, a 58-year-old gentleman received combined chemoradiation for small cell lung cancer of the right lung (limited disease) resulting in a cure. (a) Shows a follow-up computed…
for Esophageal Cancer
© Springer International Publishing Switerzland 2016Carsten Nieder and Johannes Langendijk (eds.)Re-Irradiation: New FrontiersMedical Radiology10.1007/174_2016_77 Re-irradiation for Esophageal Cancer Stefano Arcangeli1 and Vittorio Donato1 (1) Department of Radiation Oncology, S. Camillo and Forlanini Hospitals, Rome, Italy …